PR

BENTONVILLE AR – Glucose Health, Inc. (OTC: “GLUC”) confirms the following selected financial data for the 2019 fiscal year ended December 31, 2019, posted today at OTCMarkets.com.

1. Fiscal 2019 Revenue of $291,213 compared with $197,500 for Fiscal 2018; a 47% year-over-year increase.
2. GLUCODOWN® sales at Walmart up 28% year-over-year, 2019 vs. 2018.
3. GLUCODOWN® sales at Amazon up 224% year-over-year, 2019 vs. 2018.
4. Total Debts & Liabilities of $380,652 at December 31, 2019, vs. $559,995 at December 31, 2018; a 32% reduction.
...

BENTONVILLE AR – Glucose Health, Inc. (OTC: “GLUC”) confirms the following selected financial data for the period ended September 30, 2019, posted today at OTCMarkets.com.

1. 3^rd Quarter Revenue of $66,298 at September 30, 2019, compared with $50,899 for the same period in 2018; a 30% increase.
2. 3^rd Quarter Gross Profit of $23,202 at September 30, 2019, compared with $12,202 for the same period in 2018; a 91% increase.
3. Revenue of $223,494 for the Nine-Month Period ended September 30, 2019   compared with Revenue
...

BENTONVILLE AR – Glucose Health, Inc. (OTC: “GLUC”) confirms the following selected financial data for the period ended June 30, 2019, posted today at OTCMarkets.com.

1. Revenue of $135,489 at June 30, 2019, compared with $107,160 for the same period in 2018; a 26% increase.
2. Gross Profit of $52,725 at June 30, 2019, compared with $45,907 for the same period in 2018; a 15% increase.
3. 2019 Total Liabilities of $425,601 at June 30, 2019, compared with $559,995 at June 30, 2018; a 24% decrease.

Murray Fleming, CEO of...